Detalles de la búsqueda
1.
A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events.
Ann Intern Med
; 142(2): 95-104, 2005 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-15657157
2.
The effect of gemfibrozil, niacin and cholestyramine combination therapy on metabolic syndrome in the Armed Forces Regression Study.
Am J Med Sci
; 341(5): 378-82, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21358314
3.
Impact of increases in high-density lipoprotein cholesterol on cardiovascular outcomes during the armed forces regression study.
J Cardiovasc Pharmacol Ther
; 15(4): 380-3, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20693158
4.
Impact of fibrinogen levels on angiographic progression and 12-year survival in the armed forces regression study.
Angiology
; 61(4): 333-7, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20304867
5.
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS).
Am J Cardiol
; 104(11): 1457-64, 2009 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19932775
Resultados
1 -
5
de 5
1
Próxima >
>>